Monogram Orthopaedics

Linking 3D printing, machine learning, and robotics for high precision implantsMonogram Orthopaedics is attempting to refine a potentially revolutionary approach to joint implant surgery. Our model utilizes machine learning and 3D printing to create customized and patient specific implants. By linking 3D printed implants and advanced robotics via automated digital image analysis algorithms, Monogram has achieved greater stability, implant insertion accuracy, and fit than current conventional methods, based on our collaborative study with UCLA Biomechanics Laboratory.Problem:Innovation in orthopedics is slow and inefficient. Large interdependent oligopolistic companies dominate the market with implants that are almost indistinguishable and robotic technology that is costly, limited, slow, and replaceable. As it stands today, almost all of the robotically inserted implants could be inserted with manual instruments. The cost of capital, distribution, and development have built almost insurmountable barriers to entry which has led to four companies having a monopoly of over 76% of the $18B market. Solution:Monogram’s technology enables auto-segmentation of images and auto-generation of implants that will be 3D printed and inserted with our navigated robotic system. This model allows us to create and insert custom implants at scale to tackle the high-volume joint replacement surgery market – there are at least 700,000 knee replacements and 300,000 hip replacement surgeries performed in the United States each year. In collaboration with UCLA Biomechanics Laboratory, our implants have demonstrated a 7x improvement in stability. Based on internal testing we have shown a 7x improvement in bone contact, or fit, and a 13mm improvement in accuracy. Monogram has re-imagined implants for the 21st century. High precision, fully patient specific implants with state-of-the-art robotics to solve real clinical problems.

$1,000 – Quarterly investor updates.
$25,000 – Above plus newly designed Monogram t-shirt.
$100,000 – Above plus participation in regularly scheduled quarterly call with Monogram senior management.
$250,000 – Above plus arranged, paid airfare (domestic or domestic equivalent airfare towards international) to a Monogram location for in-person investor tour and a one-time dinner with management. Also includes invitation to annual updates (dinners, calls, etc.) with the Monogram senior management team.

It is advised that you consult a tax professional to fully understand any potential tax implications of receiving investor perks before making an investment.

Raised $2mm from investors including Pro-Dex, Icahn School of Medicine at Mount Sinai, and Accelerate NY
Collaborative study with the UCLA Biomechanics Laboratory demonstrated a 7x improvement in initial stability against the current standard
Experimental validation of manufacturing approach in what we believe is the first 3D printed hip solution (tested at 10 million cycles at 1,200 lbs)
Internal testing revealed 7x greater bone contact than tapered cementless stems and 13 millimeters more accuracy than conventional methods
Exclusive License Agreement with Icahn School of Medicine for pending patent substantially developed by Monogram Founder, Dr. Unis

General Expenses: 20%

Implant Mechanical Testing: 14%

Intellectual Property Filings: 13%

Optical Tracking Integration: 53%

Douglas Unis, Md
Founder and Chief Medical Officer
Dr. Unis is a board certified orthopedic surgeon specializing in adult reconstructive surgery and is the founder and Chief Medical Officer of Monogram Orthopedics. Dr. Unis founded Monogram Orthopedics in 2015. Dr. Unis has served as an Associate Professor at the Icahn School of Medicine since November 2015 and has been a practicing surgeon since 2004. Dr. Unis has consulted with many orthopedic companies including Zimmer Biomet and Think Surgical. Prior to founding Monogram Othopedics Dr. Unis was a consultant with Think Surgical, working to help with the development of their robotic total hip and knee arthroplasty system. Dr. Unis is recognized as a leader and innovator in the NYC area, having performed one of the regions’ first muscle sparing anterior total hip replacement in 2005. Dr. Unis earned his BA from Duke University and Doctor of Medicine from Case Western Reserve University and later completing his residency at Northwestern University and a fellowship from Rush University in Adult Reconstruction.   

Benjamin Sexson
Chief Executive Officer
Mr. Benjamin Sexson is the Chief Executive Officer of Monogram Orthopedics. Prior to joining Monogram, Mr. Sexson served as the Director of Business Development at Pro-Dex, an OEM manufacturer of Orthopedic Robotic End-Effectors. In his tenure at Pro-Dex, Mr. Sexson was responsible for the development, management, and launch of a proprietary product solution, helping to negate a distribution agreement with a major strategic partner. In addition, Mr. Sexson helped land and negotiate two additional development agreements and helped to expand the company’s addressable markets from CMF to Thoracic, Trauma, Spine, and Extremities. Mr. Sexson is a named inventor on multiple patent applications at Pro-Dex. Prior to joining Pro-Dex, Mr. Sexson started Brides & Hairpins, a successful B2B retail brand that currently supplies Nordstrom, Bloomingdales, and Urban Outfitters. Prior to that Mr. Sexson worked in various finance positions and is a CFA Charterholder.  Mr. Sexson graduated with honors from Caltech in Mechanical Engineering.

Round type: Series A Round size: US $20,000,000 Minimum investment: US $1,000 Target Minimum: US $2,750,000 Security Type: Preferred Equity Share price: US $4.0 Pre-money valuation: US $21,250,000 Option pool: 2.0% Liquidation preference: 1.0x Raised to date: US $1,244,808